NL-OMON29596尚未招募不适用
Active Monitoring versus an Abduction Device for treatment of Infants with Centered Dysplastic Hips, a RCT(TReatment with Active Monitoring (TRAM)-Trial)
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 800
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In order to be eligible for participation in this study, a subject must meet all of the following criteria:
- •Graf IIb or IIc DDH, diagnosed with ultrasound; Age 10-16 weeks; In case of a bilateral DDH, the hip with the worst Graf classification will be included; Good command of Dutch language of the parents; Parental informed consent
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study: Hip instability; Age <10 weeks or >16 weeks; (Suspicion of) syndromal disease (e.g. arthrogryposis, cerebral palsy, Down syndrome); Prematurity (defined as a gestational age <37 weeks).
研究者
相似试验
招募中
不适用
Active monitoring versus an abduction device for treatment of infants with centered dysplastic hips: a RCT. TReatment with Active Monitoring (TRAM-Trial)abnormal hip developmenthip dysplasia10028396NL-OMON56369niversiteit Maastricht800
尚未招募
不适用
Care Assessment Platform Research ProjectACTRN12606000295549CSIRO (E-Health Research Centre)40
进行中（未招募）
不适用
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCISDuctal Carcinoma in SituDCISNCT02926911Alliance Foundation Trials, LLC.997
招募中
不适用
Active surveillance for favorable and intermediate risk prostate cancer (PRIAS-JAPAN)prostate cancerJPRN-UMIN000048095Kagawa University1,900
进行中（未招募）
不适用
Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly PatientsSkin Basal Cell CarcinomaNCT06539468University of Michigan Rogel Cancer Center81